Detalles de la búsqueda
1.
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet
; 397(10288): 1895-1904, 2021 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33971152
2.
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
JAMA Netw Open
; 6(8): e2327637, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552479
3.
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
Clin Nucl Med
; 48(4): e153-e159, 2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754362
4.
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
J Nucl Med
; 64(4): 586-591, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328489
5.
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
J Clin Oncol
; 41(17): 3217-3224, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104723
6.
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.
J Clin Oncol
; 41(17): 3203-3216, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104748
7.
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects.
Int J Radiat Oncol Biol Phys
; 113(5): 1003-1014, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417762
8.
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer.
Eur Urol Open Sci
; 37: 80-89, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243392
9.
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
Eur Urol Oncol
; 5(2): 246-250, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249864
10.
Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer.
Adv Radiat Oncol
; 6(6): 100803, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34703954
11.
Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy.
Clin Genitourin Cancer
; 19(3): 255-266.e7, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32972877
12.
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
Brachytherapy
; 20(6): 1130-1138, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417136
13.
Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
JAMA Netw Open
; 3(12): e2025143, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301015
14.
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
Brachytherapy
; 19(5): 557-566, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624405
15.
High-dose-rate prostate brachytherapy appears safe in patients with high baseline International Prostate Symptom Scores.
Brachytherapy
; 18(6): 793-799, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31337543
16.
The effects of androgen deprivation therapy on cardiac function and heart failure: implications for management of prostate cancer.
Clin Genitourin Cancer
; 12(6): 399-407, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25193364
Resultados
1 -
16
de 16
1
Próxima >
>>